Norethindrone Acetate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Norethindrone Acetate.
| Product ID | 0555-0211_3fc82f76-249d-47fd-b598-678fb98b7ec7 |
| NDC | 0555-0211 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Norethindrone Acetate |
| Generic Name | Norethindrone Acetate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2001-06-29 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075951 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | NORETHINDRONE ACETATE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2001-06-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA075951 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2001-06-29 |
| Ingredient | Strength |
|---|---|
| NORETHINDRONE ACETATE | 5 mg/1 |
| SPL SET ID: | f73f9807-4af6-4faa-ba9a-656a47a4c5e0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0179-0227 | Norethindrone Acetate | Norethindrone Acetate |
| 0378-7291 | Norethindrone Acetate | Norethindrone Acetate |
| 0555-0211 | Norethindrone Acetate | Norethindrone Acetate |
| 16571-658 | Norethindrone acetate | norethindrone acetate |
| 42291-650 | Norethindrone Acetate | Norethindrone |
| 50268-602 | Norethindrone Acetate | Norethindrone |
| 50742-267 | Norethindrone acetate | norethindrone acetate |
| 65162-475 | Norethindrone Acetate | Norethindrone |
| 65862-715 | Norethindrone acetate | Norethindrone acetate |
| 68462-304 | Norethindrone Acetate | Norethindrone Acetate |
| 51285-424 | Aygestin | Norethindrone Acetate |